Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

Peptides

Volumn 32, Issue 9, 2011, Pages 1807-1814

  Pompilio, A ^a   Scocchi, M ^b   Pomponio, S ^a   Guida, F ^b   Di Primio, A ^a   Fiscarelli, E ^c   Gennaro, R ^b   Di Bonaventura, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Antibiotic; Antimicrobial peptide; Cathelicidin; Cystic fibrosis; Multidrug resistance

Indexed keywords

BAC7(1 35) PEPTIDE; BMAP 27; BMAP 28; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INDOLICIDIN; PEPTIDE; SMAP 29; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; CYSTIC FIBROSIS; ISOLATION PROCEDURE; KINETICS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; BLOOD PROTEINS; CATHELICIDINS; CATTLE; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; PROTEINS; PSEUDOMONAS AERUGINOSA; SHEEP; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TOBRAMYCIN;

STAPHYLOCOCCUS AUREUS;

EID: 80052783463     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.08.002     Document Type: Article

References (53)

1. A. Arzese, B. Skerlavaj, L. Tomasinsig, R. Gennaro, and M. Zanetti Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia J Antimicrob Chemother 52 2003 375 381 (Pubitemid 37120715)
2. L. Bagella, M. Scocchi, and M. Zanetti cDNA sequences of three sheep myeloid cathelicidins FEBS Lett 376 1995 225 228
3. M. Benincasa, M. Scocchi, S. Pacor, A. Tossi, D. Nobili, and G. Basaglia Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts J Antimicrob Chemother 58 2006 950 959
4. M. Benincasa, M. Scocchi, E. Podda, B. Skerlavaj, L. Dolzani, and R. Gennaro Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates Peptides 25 2004 2055 2061 (Pubitemid 39574445)
5. C. Chan, L.L. Burrows, and C.M. Deber Helix induction in antimicrobial peptides by alginate in biofilms J Biol Chem 279 2004 38749 38754 (Pubitemid 39296032)
6. D.I. Chan, E.J. Prenner, and H.J. Vogel Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action Biochim Biophys Acta 1758 2006 1184 1202 (Pubitemid 44444830)
7. S.K. Chennupati, A.G. Chiu, E. Tamashiro, C.A. Banks, M.B. Cohen, and B.S. Bleier Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis Am J Rhinol Allergy 23 2009 46 51
8. G.D. Christensen, W.A. Simpson, J.J. Younger, L.M. Baddour, F.F. Barrett, and D.M. Melton Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices J Clin Microbiol 22 1985 996 1006 (Pubitemid 16222727)
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th Informational supplement, M100-S18. Wayne, PA; 2008.
10. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: a common cause of persistent infections Science 284 1999 1318 1322 (Pubitemid 29289651)
11. Cystic Fibrosis Foundation Patient registry 1999 annual data report 2000 Cystic Fibrosis Foundation Bethesda, MD
12. E.C. Dasenbrook, W. Checkley, C.A. Merlo, M.W. Konstan, N. Lechtzin, and M.P. Boyle Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis JAMA 303 2010 2386 2392
13. R.M. Dawson, and C.Q. Liu Cathelicidin peptide SMAP-29: comprehensive review of its properties and potential as a novel class of antibiotics Drug Dev Res 70 2009 481 498
14. A.M. de Vrankrijker, T.F. Wolfs, and C.K. van der Ent Challenging and emerging pathogens in cystic fibrosis Paediatr Respir Rev 11 2010 246 254
15. G. Di Bonaventura, G. Prosseda, F. Del Chierico, S. Cannavacciuolo, P. Cipriani, and A. Petrucca Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis Int J Immunopathol Pharmacol 20 2007 529 537 (Pubitemid 47531056)
16. L.S. Elting, N. Khardori, G.P. Bodey, and V. Fainstein Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors Infect Control Hosp Epidemiol 11 1990 134 138
17. J. Emerson, S. McNamara, A.M. Buccat, K. Worrell, and J.L. Burns Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008 Pediatr Pulmonol 45 2010 363 370
18. J. Emerson, M. Rosenfeld, S. McNamara, B. Ramsey, and R.L. Gibson Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis Pediatr Pulmonol 34 2002 91 100 (Pubitemid 34809519)
19. M. Foschiatti, P. Cescutti, A. Tossi, and R. Rizzo Inhibition of cathelicidin activity by bacterial exopolysaccharides Mol Microbiol 72 2009 1137 1146
20. C.H. Goss, N. Mayer-Hamblett, M.L. Aitken, G.D. Rubenfeld, and B.W. Ramsey Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis Thorax 59 2004 955 959 (Pubitemid 39490780)
21. J.R. Govan, and V. Deretic Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol Rev 60 1996 539 574 (Pubitemid 26303478)
22. R.E. Hancock, and H.G. Sahl Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 2006 1551 1557 (Pubitemid 44967479)
23. P.S. Hiemstra The role of epithelial beta-defensins and cathelicidins in host defense of the lung Exp Lung Res 33 10 2007 537 542 (Pubitemid 350256088)
24. L.R. Hoffman, D.A. D'Argenio, M.J. MacCoss, Z. Zhang, R.A. Jones, and S.I. Miller Aminoglycoside antibiotics induce bacterial biofilm formation Nature 436 2005 1171 1175 (Pubitemid 41232296)
25. T.P. Huang, E.B. Somers, and A.C. Wong Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia J Bacteriol 188 2006 3116 3120
26. E.A. Izano, M.A. Amarante, W.B. Kher, and J.B. Kaplan Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms Appl Environ Microbiol 74 2008 470 476
27. Y. Kai-Larsen, and B. Agerberth The role of the multifunctional peptide LL-37 in host defense Front Biosci 13 2008 3760 3767 (Pubitemid 351594656)
28. F. Karpati, A.S. Malmborg, H. Alfredsson, L. Hjelte, and B. Strandvik Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population Infection 22 1994 258 263 (Pubitemid 24255177)
29. B.J. Kuipers, and H. Gruppen Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis J Agric Food Chem 55 2007 5445 5451 (Pubitemid 47092913)
30. Y. Lai, and R.L. Gallo AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense Trends Immunol 30 2009 131 141
31. R.I. Lehrer, and T. Ganz Cathelicidins: a family of endogenous antimicrobial peptides Curr Opin Hematol 9 2002 18 22 (Pubitemid 34025307)
32. J.F. Linares, I. Gustafsson, F. Baquero, and J.L. Martinez Antibiotics as intermicrobial signaling agents instead of weapons Proc Natl Acad Sci USA 103 2006 19484 19489 (Pubitemid 46026057)
33. V. Marchac, A. Equi, C. Le Bihan-Benjamin, M. Hodson, and A. Bush Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients Eur Respir J 23 2004 98 102 (Pubitemid 38088504)
34. A. Molina, R. Del Campo, L. Maiz, M.I. Morosini, A. Lamas, and F. Baquero High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation J Antimicrob Chemother 62 2008 961 967
35. N. Mookherjee, L.M. Rehaume, and R.E. Hancock Cathelicidins and functional analogues as antisepsis molecules Expert Opin Ther Targets 11 2007 993 1004 (Pubitemid 47240677)
36. F. Morgera, L. Vaccari, N. Antcheva, D. Scaini, S. Pacor, and A. Tossi Primate cathelicidin orthologues display different structures and membrane interactions Biochem J 417 2009 727 735
37. A. Nijnik, and R.E. Hancock The roles of cathelicidin LL-37 in immune defences and novel clinical applications Curr Opin Hematol 16 2009 41 47
38. J. Overhage, A. Campisano, M. Bains, E.C. Torfs, B.H. Rehm, and R.E. Hancock Human host defense peptide LL-37 prevents bacterial biofilm formation Infect Immun 76 2008 4176 4182
39. A. Pompilio, V. Crocetta, P. Confalone, M. Nicoletti, A. Petrucca, and S. Guarnieri Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients BMC Microbiol 10 2010 102
40. A. Prayle, and A.R. Smyth Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity Curr Opin Pulm Med 16 2010 604 610
41. L. Saiman, F. Mehar, W.W. Niu, H.C. Neu, K.J. Shaw, and G. Miller Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation Clin Infect Dis 23 1996 532 537 (Pubitemid 26304503)
42. L. Saiman, S. Tabibi, T.D. Starner, P. San Gabriel, P.L. Winokur, and H.P. Jia Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis Antimicrob Agents Chemother 45 2001 2838 2844 (Pubitemid 32906680)
43. P.K. Singh, A.L. Schaefer, M.R. Parsek, T.O. Moninger, M.J. Welsh, and E.P. Greenberg Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms Nature 407 2000 762 764
44. B. Skerlavaj, M. Benincasa, A. Risso, M. Zanetti, and R. Gennaro SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes FEBS Lett 463 1999 58 62 (Pubitemid 30001718)
45. B. Skerlavaj, R. Gennaro, L. Bagella, L. Merluzzi, A. Risso, and M. Zanetti Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities J Biol Chem 271 1996 28375 28381 (Pubitemid 26374655)
46. R.C. Spencer The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia J Hosp Infect 30 Suppl. 1995 453 464
47. L. Spicuzza, C. Sciuto, G. Vitaliti, G. Di Dio, S. Leonardi, and M. La Rosa Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients Eur J Clin Microbiol Infect Dis 28 2009 191 195
48. W.J. Waddell A simple ultraviolet spectrophotometric method for the determination of protein J Lab Clin Med 48 1956 311 314
49. D. Yang, A. Biragyn, L.W. Kwak, and J.J. Oppenheim Mammalian defensins in immunity: more than just microbicidal Trends Immunol 23 2002 291 296 (Pubitemid 34628771)
50. M. Zanetti Cathelicidins, multifunctional peptides of the innate immunity J Leukoc Biol 75 2004 39 48 (Pubitemid 38166778)
51. M. Zanetti, R. Gennaro, and D. Romeo Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain FEBS Lett 374 1995 1 5
52. M. Zanetti, R. Gennaro, M. Scocchi, and B. Skerlavaj Structure and biology of cathelicidins Adv Exp Med Biol 479 2000 203 218 (Pubitemid 32193310)
53. M. Zanetti, R. Gennaro, B. Skerlavaj, L. Tomasinsig, and R. Circo Cathelicidin peptides as candidates for a novel class of antimicrobials Curr Pharm Des 8 2002 779 793 (Pubitemid 34498565)